It remains controversial whether the levels of complement components (C3, C4, CFB, CFD, etc.)are elevated or decreased in NASH, and there is no authoritative evidence to support their correlation. The gene discussed is CFB; the disease is metabolic dysfunction-associated steatohepatitis.